HKSE:02190 (China)
Â
Class H
HK$
19.95
+0.59 (+3.05%)
Aug 17
Business Description
Zylox-Tonbridge Medical Technology Co Ltd
ISIN : CNE100004JD2
Share Class Description:
HKSE:02190: Class HTotal Employee Number:
925Compare
Compare
Traded in other countries / regions
02190.Hong Kong818.Germany IPO Date
2021-07-05Description
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 27.21 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.02 | |||||
Debt-to-EBITDA | 0.27 | |||||
Interest Coverage | 219.7 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 11.28 | |||||
Beneish M-Score | -1.94 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 47.3 | |||||
3-Year Book Growth Rate | 1.2 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 24.56 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.97 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.39 | |||||
9-Day RSI | 50.02 | |||||
14-Day RSI | 50.22 | |||||
3-1 Month Momentum % | -11.69 | |||||
6-1 Month Momentum % | -15.43 | |||||
12-1 Month Momentum % | -12.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.98 | |||||
Quick Ratio | 5.44 | |||||
Cash Ratio | 5.32 | |||||
Days Inventory | 236.32 | |||||
Days Sales Outstanding | 1.41 | |||||
Days Payable | 82.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.26 | |||||
Dividend Payout Ratio | 0.13 | |||||
Forward Dividend Yield % | 1.26 | |||||
5-Year Yield-on-Cost % | 1.26 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 3.36 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 72.15 | |||||
Operating Margin % | 21.09 | |||||
Net Margin % | 23.1 | |||||
EBITDA Margin % | 22.52 | |||||
FCF Margin % | 25.9 | |||||
OCF Margin % | 36.42 | |||||
ROE % | 7.8 | |||||
ROA % | 7.03 | |||||
ROIC % | 12.25 | |||||
3-Year ROIIC % | 100 | |||||
ROC (Joel Greenblatt) % | 36.84 | |||||
ROCE % | 7.55 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 24.07 | |||||
Forward PE Ratio | 16.57 | |||||
PE Ratio without NRI | 24.01 | |||||
Price-to-Owner-Earnings | 28.84 | |||||
PS Ratio | 5.57 | |||||
PB Ratio | 1.84 | |||||
Price-to-Tangible-Book | 1.88 | |||||
Price-to-Free-Cash-Flow | 21.43 | |||||
Price-to-Operating-Cash-Flow | 15.23 | |||||
EV-to-EBIT | 16.88 | |||||
EV-to-EBITDA | 16.83 | |||||
EV-to-Revenue | 3.79 | |||||
EV-to-FCF | 14.64 | |||||
Price-to-GF-Value | 0.56 | |||||
Price-to-Graham-Number | 1.42 | |||||
| Price-to-Net-Current-Asset-Value | 3.7 | |||||
| Price-to-Net-Cash | 4.27 | |||||
Earnings Yield (Greenblatt) % | 5.92 | |||||
FCF Yield % | 4.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zylox-Tonbridge Medical Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,162.61 | ||
| EPS (TTM) (HK$) | 0.829 | ||
| Beta | 0.8162 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 0.79 | ||
| Volatility % | 25.74 | ||
| 14-Day RSI | 50.22 | ||
| 14-Day ATR (HK$) | 0.687751 | ||
| 20-Day SMA (HK$) | 19.259 | ||
| 12-1 Month Momentum % | -12.16 | ||
| 52-Week Range (HK$) | 17.1 - 28 | ||
| Shares Outstanding (Mil) | 331.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zylox-Tonbridge Medical Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zylox-Tonbridge Medical Technology Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.251576 Cash Dividend | 2026-05-27 | 21.00 (+0.38%) | ||
| HKD 0.108991 Cash Dividend | 2025-06-04 | 19.06 (+1.38%) |
Show
Entries
Zylox-Tonbridge Medical Technology Co Ltd Frequently Asked Questions
What is Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190)'s stock price today?
The current price of HKSE:02190 is HK$19.95. The 52 week high of HKSE:02190 is HK$28.00 and 52 week low is HK$17.10.
When is next earnings date of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190)?
The next earnings date of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) is .
Does Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) pay dividends? If so, how much?
The Dividend Yield %  of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) is 1.26% (As of Today), Highest Dividend Payout Ratio of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) was 0.13. The lowest was 0.13. And the median was 0.13. The  Forward Dividend Yield % of Zylox-Tonbridge Medical Technology Co Ltd(HKSE:02190) is 1.26%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Zylox-Tonbridge Medical Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers